Sector valuations Merck & Co., Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 07:29:32 18/06/2026 pm IST			5-day change	1st Jan Change
113.42 ^USD	-1.75%		-5.19%	+8.77%

05:36pm	Merck Receives U.S. FDA Approval for Expanded Indication of CAPVAXIVE Pneumococcal 21-Valent Conjugate Vaccine in Children and Adolescents Aged 2 Through 17 At Increased Risk for Pneumococcal Disease	CI
04:52pm	Merck Says FDA Approved Capvaxive in High-Risk Pediatric Patients	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	Price to Book (N)	PEG (N)	EV / Sales (N)	EV / EBITDA (N)	EV / EBIT (N)	Dividend Yield (N)	Capi.($)
MERCK & CO., INC.	51.5x	5.86x	-0.74x	4.81x	19.55x	27.16x	2.9%	29TCr
MERCK KGAA	22.53x	1.89x	-16.87x	3.11x	11.07x	18.15x	1.74%	6.72TCr
HALOZYME THERAPEUTICS, INC.	10.19x	10.78x	0.06x	5.26x	8.1x	8.9x	-	813.33Cr
KYOWA KIRIN CO., LTD.	15.9x	1.37x	0.79x	1.99x	6.83x	8.16x	2.81%	799.45Cr
SK BIOPHARMACEUTICALS CO., LTD.	22.75x	6.34x	1.37x	6.83x	18.66x	19.48x	-.--%	467.49Cr
YUHAN CORPORATION	43.92x	2.62x	-1.43x	2.49x	30.32x	44.92x	0.7%	389.62Cr
BETTA PHARMACEUTICALS CO., LTD.	27.14x	-	0.17x	5.21x	14.9x	24.13x	-	315.96Cr
SUPERNUS PHARMACEUTICALS, INC.	100.57x	-	-0.61x	-	-	-	-.--%	252.94Cr
KISSEI PHARMACEUTICAL CO., LTD.	12.46x	0.83x	0.88x	1.11x	28.01x	-76.3x	4.1%	100.89Cr
DBV TECHNOLOGIES	-7.64x	12.77x	0.47x	211.78x	-6.82x	-5.34x	-.--%	100Cr
OSCOTEC INC.	49.64x	7.78x	-1.29x	16.81x	35.31x	41.54x	-	105.47Cr
ETON PHARMACEUTICALS, INC.	45.29x	-	-0.09x	-	-	-	-	90Cr
Average	32.85x	5.58x	-1.44x	25.94x	16.59x	11.08x	1.53%	3.22TCr
Weighted average by Cap.	44.28x	5.15x	-3.46x	5.03x	17.61x	24.54x	2.6%